Siemens Holds Live Demonstrations of Groundbreaking, New Innovations in Imaging, Diagnostics and Therapy
|
By MedImaging International staff writers Posted on 04 Mar 2021 |

Illustration
Siemens Healthineers (Erlangen, Germany) highlighted its latest new innovations at the European Congress of Radiology (ECR) virtual event, March 3-10, 2021 that can help enhance access to care and leverage AI to revolutionize clinical decision making.
At the fully online ECR 2021 event held in Vienna, Austria, Siemens offered live product demonstrations of its groundbreaking, new innovations in imaging, diagnostics and therapy at its virtual ECR booth. Among its new innovations and solutions highlighted at ECR 2021 was its Magnetom Free.Max, a new class of magnetic resonance imaging (MRI) systems that the company calls “High-V MRI.” The scanner’s unique combination of digital technologies and the new field strength of 0.55 tesla broaden the range of clinical applications for MRI systems. Magnetom Free.Max considerably improves pulmonary imaging with MRI and allows patients with implants to be scanned much more accurately. Magnetom Free.Max can be installed in places where MRI used to be impossible. At just over three metric tons in weight and just below two meters in transportation height, the machine is the most lightweight as well as the most compact whole-body scanner Siemens has ever built.
Siemens also demonstrated Syngo Carbon, an all-in-one solution for easy access to all relevant data generated in the processes of imaging and reporting. Data from different departments is drawn out from various silos and integrated as part of a unified environment, including diagnostics and assessment, simplifying workflows, and making it easier for different areas to work together. Among its new innovations in molecular imaging, Siemens demonstrated Biograph Vision Quadra, a CE-Marked positron emission tomography/computed tomography (PET/CT) scanner that is designed for clinical use as well as translational research - or the application of scientific research to create therapies and procedures that improve health outcomes. In this manner, the Biograph Vision Quadra expands precision medicine.
At ECR 2021, Siemens also introduced new innovations in breast care and participated in the Breast Care Symposium where key opinion leaders in breast imaging elaborated different breast imaging modalities – from traditional breast imaging to MRI and ultrasound.
Related Links:
Siemens Healthineers
At the fully online ECR 2021 event held in Vienna, Austria, Siemens offered live product demonstrations of its groundbreaking, new innovations in imaging, diagnostics and therapy at its virtual ECR booth. Among its new innovations and solutions highlighted at ECR 2021 was its Magnetom Free.Max, a new class of magnetic resonance imaging (MRI) systems that the company calls “High-V MRI.” The scanner’s unique combination of digital technologies and the new field strength of 0.55 tesla broaden the range of clinical applications for MRI systems. Magnetom Free.Max considerably improves pulmonary imaging with MRI and allows patients with implants to be scanned much more accurately. Magnetom Free.Max can be installed in places where MRI used to be impossible. At just over three metric tons in weight and just below two meters in transportation height, the machine is the most lightweight as well as the most compact whole-body scanner Siemens has ever built.
Siemens also demonstrated Syngo Carbon, an all-in-one solution for easy access to all relevant data generated in the processes of imaging and reporting. Data from different departments is drawn out from various silos and integrated as part of a unified environment, including diagnostics and assessment, simplifying workflows, and making it easier for different areas to work together. Among its new innovations in molecular imaging, Siemens demonstrated Biograph Vision Quadra, a CE-Marked positron emission tomography/computed tomography (PET/CT) scanner that is designed for clinical use as well as translational research - or the application of scientific research to create therapies and procedures that improve health outcomes. In this manner, the Biograph Vision Quadra expands precision medicine.
At ECR 2021, Siemens also introduced new innovations in breast care and participated in the Breast Care Symposium where key opinion leaders in breast imaging elaborated different breast imaging modalities – from traditional breast imaging to MRI and ultrasound.
Related Links:
Siemens Healthineers
Latest ECR 2021 News
- GE Healthcare Showcases Innovative AI, Digital and Imaging Solutions at ECR 2021
- Hitachi Unveils MRI Systems with Human-Centered Design at ECR 2021
- Mindray Showcases Advanced Imaging and Laboratory Diagnostic Solutions at ECR 2021
- Vieworks Presents Next Generation Photon-Understanding Detector Solution Powered by AI
- First Ever Autonomous AI Medical Imaging Application Previewed at ECR 2021
- VUNO Presents State-of-the-Art AI Medical Imaging Technology at ECR 2021
- Agfa Launches Groundbreaking SmartXR Artificial Intelligence on Its Mobile DR 100s
- Canon Demonstrates How AI Can Help to Drive Workflow in COVID-19 Era
- Shimadzu Showcases Latest Lab and Imaging Technologies at ECR 2021
- Carestream Showcases New Glass-Free Detector and Intelligent Solutions for Digital Radiography at Virtual ECR 2021
- Hologic Showcases New Genius AI Powered Imaging Technology for Breast Health Care
- Philips Spotlights New and Enhanced Diagnostic and AI-Enabled Solutions to Streamline Workflows Across Imaging Enterprise
- Konica Minolta Launches New Solutions in Healthcare IT, X-Ray and Ultrasound Imaging at ECR 2021
- ECR 2021 Virtual Exhibition Features One of the Biggest-Ever Online Programs in Radiology
Channels
Radiography
view channel
Routine Mammograms Could Predict Future Cardiovascular Disease in Women
Mammograms are widely used to screen for breast cancer, but they may also contain overlooked clues about cardiovascular health. Calcium deposits in the arteries of the breast signal stiffening blood vessels,... Read more
AI Detects Early Signs of Aging from Chest X-Rays
Chronological age does not always reflect how fast the body is truly aging, and current biological age tests often rely on DNA-based markers that may miss early organ-level decline. Detecting subtle, age-related... Read moreMRI
view channel
New Material Boosts MRI Image Quality
Magnetic resonance imaging (MRI) is a cornerstone of modern diagnostics, yet certain deep or anatomically complex tissues, including delicate structures of the eye and orbit, remain difficult to visualize clearly.... Read more
AI Model Reads and Diagnoses Brain MRI in Seconds
Brain MRI scans are critical for diagnosing strokes, hemorrhages, and other neurological disorders, but interpreting them can take hours or even days due to growing demand and limited specialist availability.... Read moreMRI Scan Breakthrough to Help Avoid Risky Invasive Tests for Heart Patients
Heart failure patients often require right heart catheterization to assess how severely their heart is struggling to pump blood, a procedure that involves inserting a tube into the heart to measure blood... Read more
MRI Scans Reveal Signature Patterns of Brain Activity to Predict Recovery from TBI
Recovery after traumatic brain injury (TBI) varies widely, with some patients regaining full function while others are left with lasting disabilities. Prognosis is especially difficult to assess in patients... Read moreUltrasound
view channel
Reusable Gel Pad Made from Tamarind Seed Could Transform Ultrasound Examinations
Ultrasound imaging depends on a conductive gel to eliminate air between the probe and the skin so sound waves can pass clearly into the body. While the imaging technology is fast, safe, and noninvasive,... Read more
AI Model Accurately Detects Placenta Accreta in Pregnancy Before Delivery
Placenta accreta spectrum (PAS) is a life-threatening pregnancy complication in which the placenta abnormally attaches to the uterine wall. The condition is a leading cause of maternal mortality and morbidity... Read moreNuclear Medicine
view channel
Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more
Cancer “Flashlight” Shows Who Can Benefit from Targeted Treatments
Targeted cancer therapies can be highly effective, but only when a patient’s tumor expresses the specific protein the treatment is designed to attack. Determining this usually requires biopsies or advanced... Read moreGeneral/Advanced Imaging
view channel
AI Tool Offers Prognosis for Patients with Head and Neck Cancer
Oropharyngeal cancer is a form of head and neck cancer that can spread through lymph nodes, significantly affecting survival and treatment decisions. Current therapies often involve combinations of surgery,... Read more
New 3D Imaging System Addresses MRI, CT and Ultrasound Limitations
Medical imaging is central to diagnosing and managing injuries, cancer, infections, and chronic diseases, yet existing tools each come with trade-offs. Ultrasound, X-ray, CT, and MRI can be costly, time-consuming,... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
Nuclear Medicine Set for Continued Growth Driven by Demand for Precision Diagnostics
Clinical imaging services face rising demand for precise molecular diagnostics and targeted radiopharmaceutical therapy as cancer and chronic disease rates climb. A new market analysis projects rapid expansion... Read more








